Multiple Sclerosis Discovery Forum
News and Future Directions
Papers
Forums
Professional Resources
Research Resources
MSGene - Gene overview of all published MS-association studies for CCR5
Gene:
CCR5
(CC-CKR-5; CCCKR5; CD195; CKR-5; CKR5; CMKBR5; FLJ78003; IDDM22)
View on AlzGene
View on PDGene
View on SZGene
Protein:
chemokine (C-C motif) receptor 5
(C-C chemokine receptor type 5; C-C motif chemokine receptor 5 A159A; OTTHUMP00000209784; chemokine receptor CCR5; chemr13)
Chromosome:
3
(View:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
X
Y
MT
)
Status:
Updated 23 November 2011
1. Case-Control Studies (by ethnic group)
MS Cases
Normal Controls
Study
Population
Source
# Polys
# Subjects
(% women)
DX
Onset Age
(range)
Age
(range)
# Subjects
(% women)
Age
(range)
Result
Caucasian
Barcellos, 2000
USA (II)
CL
1
(detail)
299
(-)
U
-
-
147
(-)
-
Negative
Barcellos, 2000
USA (I)
CL
1
(detail)
125
(-)
O/M
-
-
-
-
Negative
Bennetts, 1997
Australia
CL
1
(detail)
120
(-)
P
-
-
168
(-)
-
Negative
D’Angelo, 2011
Italy (Sicily)
CL
1
(detail)
180
(73%)
P
29.4 + 7.8
(-)
44.8 + 8
(-)
213
(71%)
44 + 11.4
(-)
Positive
Favorova, 2002
Russia
CL
1
(detail)
219
(57%)
P
23 + 9
(-)
33 + 12
(-)
354
(62%)
28 + 10
(-)
Positive
Favorova, 2006
Overlaps with
Favorova, 2002
CL
1
(detail)
268
(66%)
MD1
23 + 9
(-)
33 + 12
(-)
362
(44%)
30 + 11
(-)
n.a.
Gade-Andavolu, 2004
USA
CL
1
(detail)
132
(64%)
O/M
34.6
(18-57)
57.2
(30-86)
163
(52%)
34.3
(18-49)
Positive
Luomala, 2003
Finland
CL
1
(detail)
116
(58%)
P
-
46 + 10
(24-78)
109
(-)
46 + 10
(23-78)
Negative
Motsinger, 2007
Overlaps with
Barcellos, 2000
CL
1
(detail)
421
(-)
MD1
-
-
96
(-)
-
Negative
Otaegui, 2007
Spain (Other origin)
CL
1
(detail)
102
(-)
MD1
-
-
226
(-)
-
Positive
Otaegui, 2007
Spain (Basque)
CL
1
(detail)
62
(-)
MD1
-
-
147
(-)
-
Positive
Pulkkinen, 2004
Overlaps with
Luomala, 2003
CL
1
(detail)
89
(-)
U
32.2
(-)
46 + 10.2
(-)
119
(-)
45.7 + 10.2
(-)
n.a.
Ristic, 2006
Croatia, Slovenia
CL
1
(detail)
325
(71%)
P
29.4 + 8.9
(-)
43.1
(-)
356
(-)
-
Negative
Schreiber, 2002
Overlaps with
Sellebjerg, 2007
PO
1
(detail)
71
(-)
U
-
-
151
(-)
-
n.a.
Sellebjerg, 2000
Denmark
CL
1
(detail)
148
(73%)
P
-
33.2
(-)
151
(-)
-
Negative
Sellebjerg, 2007
Denmark
CL
2
(detail)
109
(75%)
U
-
42
(-)
105
(70%)
38
(-)
Negative
Silversides, 2004
UK (Northern Ireland)
CL,PO
1
(detail)
439
(-)
U
-
-
230
(-)
-
Trend
van Veen, 2007
Netherlands
CL
2
(detail)
729
(-)
P
-
-
177
(54%)
43
(-)
Positive
Zhang, 2005
Sweden
CL
2
(detail)
672
(72%)
P
31.5
(-)
45.6
(15-80)
672
(49%)
54.5
(17-91)
Negative
African Descent
Brassat, 2006
USA
CL
2
(detail)
442
(-)
MD1
-
-
293
(-)
-
Negative
Other/Mixed
Kaimen-Maciel, 2007
Brazil
CL
1
(detail)
124
(69%)
MD1&2
-
44.2 + 11.9
(18-79)
127
(44%)
30 + 10.1
(18-60)
Positive
Shahbazi, 2009
Iran
CL
1
(detail)
254
(83%)
MD1
26 + 7
(-)
32.2 + 8.6
(-)
380
(-)
-
Positive
Contact us
if you are an author of an association study regarding this gene and do not find your study in this table or find errors in the representation of your study details.
2. Family-Based Studies (by ethnic group)
Affecteds
Unaffecteds
Study
Population
# Polys
# Families
# Subjects
(% women)
DX
Onset Age
(range)
Age
(range)
# Subjects
(% women)
Age
(range)
Result
Caucasian
Barcellos, 2000
Overlaps with
Barcellos, 2000 (CC)
1
(detail)
125
-
O/M
-
-
-
-
n.a.
Barcellos, 2004
USA
1
(detail)
337
337
(-)
U
-
-
-
-
Negative
Chataway, 1999
UK
2
(detail)
185
-
U
-
-
-
-
Negative
Motsinger, 2007
Overlaps with
Barcellos, 2000 (CC)
1
(detail)
146
146
(-)
MD1
-
-
-
-
n.a.
Motsinger, 2007
Overlaps with
Barcellos, 2000 (CC)
1
(detail)
275
-
MD1
-
-
-
-
Negative
Contact us
if you are an author of an association study regarding this gene and do not find your study in this table or find errors in the representation of your study details.
Source:
Source of case population -> “CL” (clinic-based), “PO” (population-based), or “CO” (community-based).
# Polys:
Number of polymorphisms tested per gene and per sample.
Onset Age and Age:
Mean or median age at onset or examination, respectively.
DX:
Criteria used to determine MS diagnosis -> "P" (Poser criteria, 1983), "MD1" (McDonald criteria, 2001), "MD2" (revised McDonald criteria, 2005), "MD1&2" (McDonald criteria, 2001 and 2005), "O/M" (other/mixed), "U" (Unknown).
Result:
Overall conclusion reached by authors of the original publication (“positive” usually indicates significant (P<0.05) association in at least one of the performed analyses, and “negative” indicates no evidence for significant association, while “trend” indicates results in between).
(-)
: Either no data provided or in case of overlap, data included in original study.
Print this page
Email this page
MSDF RSS
Text size
Share & Bookmark
Del.icio.us
Digg
Facebook
Google
Newsvine
MSGene Recent Updates
STAT3
MSGene Top Results
Top Results Details
1.
HLA-DRB1
2.
IL2RA
3.
IL7R
4.
TAGAP
5.
CLEC16A
6.
EVI5
7.
GWA_16q24.1
8.
GWA_5p13.1
9.
TTC34
10.
AHI1
[see more]
[close]
11.
GWA_3q24
12.
CD226
13.
CD5
14.
IL12B
15.
PLEK
16.
IL22RA2
17.
NCOA5
18.
STAT3
19.
GWA_2p21
20.
DKKL1
21.
CYP24A1
22.
TNFRSF1A
23.
TNFSF14
24.
CD86
25.
CD58
26.
GWA_3q12.3
27.
SH2B3
28.
SP140
29.
GPR65
30.
CYP27B1
31.
CD40
32.
MAPK1
33.
ZFP36L1
34.
AGAP2
35.
RPS6KB1
36.
SOX8
37.
MPV17L2
38.
PTPRK
39.
ZMIZ1
40.
PVR
41.
HHEX
42.
C1orf106
43.
PKIA
44.
BACH2
45.
MMEL1
46.
SLC30A7
47.
BATF
48.
KIF21B
49.
SAE1
50.
DLEU1
51.
MYC
52.
SYK
53.
RGS14
54.
DDAH1
55.
MERTK
56.
ZNF767
57.
CLECL1
58.
MANBA
59.
TYK2
60.
ZBTB46
61.
CDC37
62.
NDFIP1
63.
MAP3K14
64.
RGS1
65.
TMEM39A
66.
MALT1
67.
CARD11
68.
MAF
69.
IRF5
MSGene Stats
Studies: 789
Genes: 809
Polymorphisms: 2907
Meta-analyses: 324
ALSGene
AlzGene
MSGene
PDGene
SZGene
An up-to-date collection of all published genetic association studies.
Copyright © 2024 Biomedical Research Forum LLC
Disclaimer
Copyright